Julie Krop

2016

In 2016, Julie Krop earned a total compensation of $1M as Chief Medical Officer and Senior Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 62% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$160,800
Option Awards$246,650
Salary$398,615
Stock Awards$226,620
Other$7,950
Total$1,040,635

Krop received $398.6K in salary, accounting for 38% of the total pay in 2016.

Krop also received $160.8K in non-equity incentive plan, $246.7K in option awards, $226.6K in stock awards and $8K in other compensation.

Rankings

In 2016, Julie Krop's compensation ranked 8,048th out of 14,075 executives tracked by ExecPay. In other words, Krop earned more than 42.8% of executives.

ClassificationRankingPercentile
All
8,048
out of 14,075
43rd
Division
Manufacturing
3,076
out of 5,489
44th
Major group
Chemicals And Allied Products
1,024
out of 1,895
46th
Industry group
Drugs
794
out of 1,538
48th
Industry
Pharmaceutical Preparations
629
out of 1,176
47th
Source: SEC filing on April 20, 2017.

Krop's colleagues

We found five more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2016.

2016

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2016

Nicholas Grund

AMAG Pharmaceuticals

Chief Commercial Officer

2016

Frank Thomas

AMAG Pharmaceuticals

Chief Operating Officer

2016

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2016

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

News

You may also like